Clinical practice recommendations for Bangpungtongseong-san (Bofutsusho-san) and Bangkihwangki-tang(Boiogito) in obesity

비만치료 및 체중 감량에서 방풍통성산과 방기황기탕 사용에 대한 임상 권고안

  • Park, Jung-Hyun (Dept. of Oriental Rehabilitation Medicine, Kangnam Korean Hospital Kyung-Hee University) ;
  • Kim, Ho-Jun (Dept. of Oriental Rehabilitation Medicine, College of Oriental Medicine, Dong-Guk University)
  • 박정현 (강남경희한방병원 체형관리센터) ;
  • 김호준 (동국대학교 한의과 대학 한방재활의학과)
  • Received : 2011.12.12
  • Accepted : 2011.12.30
  • Published : 2012.06.30

Abstract

Objectives These prescribing recommendations have been written to guide clinicians on the appropriate use of Bangpungtongseong-san(BT) and Bangkihwangki-tang(BH) in the treatment of obesity. These recommendation are aimed at providing evidence based information concerning diagnosis and management of obesity. Methods We collected all relevant references about treatment effect of BT and BH on obesity in the forms of meta-analysis, systematic review, randomized controlled trial, case-control study, observational study and practice guideline from international and domestic databases and paper journals. We examined treatment effect, side effects, recommendations for dose, indication and contraindication of BT and BH. Results The treatment effect of BT and BH on obesity has been proved through clinical trial. BT is indicated for obese patients (Body mass index, $BMI{\geq}25$) with strong abdomen and a tendency to constipation, BH is indicated for obese patients ($BMI{\geq}25$) with a fair skinned, soft muscled, edematous and sweat easily. Conclusion We wish the information contained in theses recommendations will help clinicians reach a reasonable and beneficial decision with evidence-based results. Further studies are strongly needed to develop better treatment strategies for herbal medicines on obesity.

Keywords

References

  1. Hasani-Ranjbar S, Nayebi N, Larijani B, Abdollahi M. A systematic review of the efficacy and safety of herbal medicines used in the treatment of obesity. World Journal of Gastroenterology. 2009;15(25):3073-85. https://doi.org/10.3748/wjg.15.3073
  2. 강경원, 문진석, 강병갑, 김보영, 신미숙, 최선미. 한방비만변증 설문지를 바탕으로 증상 척도에 따른 변증 진단 비교. 대한한방비만학회지. 2009; 9(1):37-44.
  3. 안형식. 임상진료지침의 개념과 활성화 방안. 대한소화기학회지. 2007;49(4):105-18.
  4. 김호준, 한창호, 이의주, 송윤경, 신병철, 김윤경. 비만치료 및 체중감량에서의 적절한 마황사용에 대한 임상 진료지침 개발. 대한한방비만학회지. 2007; 7(2):27-37.
  5. 박정현, 이명종, 김호준. 방풍통성산 관련 연구 분석. 한방재활의학과학회지. 2011;21(2):189-202.
  6. Takahama M. Efficacy of Boi-ogi-to in the treatment of rheumatoid arthritis. Nihon Toyo Igaku Zasshi. 1995;45(3):569-74. https://doi.org/10.3937/kampomed.45.569
  7. Noguchi J, Shudo T, Nagata K. Efficacy of Boi-ogito for ethical use for osteoarthritis of the knee with joint fluid. Seikei Saigai Geka. 2004;47:999-1005.
  8. Shimada T, Akase T, Kosugi M, Aburada M. Preventive effect of Boiogito on metabolic disorders in the TSOD Mouse, a model of spontaneous obese Type II diabetes mellitus. Evid Based Complement Alternat Med. 2009;1-8.
  9. Harbour RT, Forsyth L, Scottish Intercollegiate Guidelines Network, editors. SIGN 50: a guideline developer's handbook. Scotland: Scottish Intercollegiate Guidelines Network. 2008;57.
  10. Sackett DL. Evidence-based Medicine: How to Practice and Teach EBM. 2nd ed. New York: Churchill Livingstone. 2000.
  11. 허준. 동의보감. 서울:남산당. 1983;207-39, 285-6, 352-75, 556-9, 1717.
  12. Kampo Co. Available from: URL: http://www.tsumura.co.jp/english/.../pi/JPR_T062.pdf
  13. 劉河間. 宣明論方. 券十 문연각서고전서 중의학 대계. 서울:여강출판사. 1988;768.
  14. 張仲景. 金櫃要略方論. 서울:성보사. 1985;21,35,70.
  15. 식약청 Available from: URL: http://ezdrug.kfda.go.kr
  16. 최은미, 류은경. 비만 환자에 대한 방풍통성산의 치료효과. 대한한방비만학회지. 2001;1(1):1-11.
  17. 배정환, 정석희, 이종수, 김성수, 신현대. 비만 환자에 있어 양해(방풍통성산)의 유용성 평가를 위한 임상시험. 한방재활의학과학회지. 2002;13(1):37-46.
  18. 신대희, 조국현, 이혁, 문미경, 강대길, 윤용갑, 박도심, 정선관, 이호섭. 방풍통성산이 비만인에 미치는 영향에 대한 임상적 연구. 대한한의학방제학회지. 2008;16(2):133-44.
  19. 이지은, 송윤경, 임형호. 비만환자에 대한 방풍 통성산의 무작위배정, 이중맹검, 위약-대조군 임상시험. 대한한방비만학회지. 2010;10(1):1-16.
  20. 박정현, 이명종, 김호준, 홍선우, 이동기, 유재욱, 최선미, 문진석, 임지연, 이정복. 비만환자에 서 한방 비만 변증에 따른 방풍통성산과 방기황 기탕의 치료 효과 및 부작용 비교. 한방재활의학과학회지. 2011;21(2):265-78.
  21. Itoh T, Senda S, Inoue H, Saitoh Y, Kagami M, Matsubara F, Aoyagi H. The Effect of Bofutsushosan on weight reduction in human. Japanese Journal of Oriental Medicine 2005; 56(6);933-9.
  22. Akiyama T, Yoshikawa H, Tanaka H. Efficacy of Bofutsushosan for a patient worrying about obesity with gene mutation ${\beta}$-adrenergic receptors. Digestion and Absorption. 1998;21(2):159-62.
  23. Hioki C, Yoshimoto K, Yoshida T. Efficacy of Bofutsusho-san, an oriental herbal medicine, in obese Japanese women with impaired glucose tolerance. Clinical Experimental Pharmacological Physiology. 2004;31(9):614-9. https://doi.org/10.1111/j.1440-1681.2004.04056.x
  24. Hioki C, Yoshimoto K, Yoshida T. Traditional medicine Bofutsusho-san, improves hyperinsulinemia in obese subjects. Journal of Chinese Medicine. 2008;3(6):312-6.
  25. 吉田麻美. 防己黃芪湯對肥滿型糖尿病的效果. 日本東洋醫學雜誌. 1998;49:249-56.
  26. 문진석, 강병갑, 류은경, 최선미. 한의사와 환자의 설문을 통한 비만 변증지표 연구. 대한한방비만학회지. 2007;7(1)55-69.
  27. 박정현. 방풍통성산과 방기황기탕의 비만 변증 및 유전자다형성에 따른 치료 효과. 동국대학교논문집. 2011.
  28. 이기훈, 장규태. 방풍통성산으로 치료한 소아 건선 3례. 대한한방소아과학회지. 2009;23(3):207-16.
  29. 윤길영. 동의임상방제학. 서울:명보출판사. 1992; 52-4.
  30. 이종대. 빈용 101 처방. 서울:정담출판사. 2004;978.
  31. WHO Western Pacific Region, International Association for the Study of Obesity, International Obesity Task Force. The Asia-Pacific perspective: Redefining obesity and its treatment. 2002;15-21.
  32. Plodkowski RA, St Jeor ST. Medical nutrition therapy for the treatment of obesity. Endocrinol Metab Clin North Am. 2003;32:935-69. https://doi.org/10.1016/S0889-8529(03)00077-X
  33. Hensrud DD. Pharmacotherapy for obesity. Med Clin North Am. 2000;84:463-76. https://doi.org/10.1016/S0025-7125(05)70231-5
  34. 유순집. 비만의 약물치료. 대한내분비학회지. 2008; 23(4):223-33.